SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-003686
Filing Date
2020-11-04
Accepted
2020-11-04 11:21:27
Documents
55
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cannabics_10k-083120.htm 10-K 743779
2 CERTIFICATION cannabics_ex3101.htm EX-31.1 10720
3 CERTIFICATION cannabics_ex3102.htm EX-31.2 10925
4 CERTIFICATION cannabics_ex3201.htm EX-32.1 4381
5 CERTIFICATION cannabics_ex3202.htm EX-32.2 4282
6 GRAPHIC image_001.jpg GRAPHIC 37107
7 GRAPHIC image_002.jpg GRAPHIC 15785
8 GRAPHIC image_003.jpg GRAPHIC 16560
9 GRAPHIC image_004.jpg GRAPHIC 53013
  Complete submission text file 0001683168-20-003686.txt   2511913

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE cnbx-20200831.xml EX-101.INS 262763
11 XBRL SCHEMA FILE cnbx-20200831.xsd EX-101.SCH 22326
12 XBRL CALCULATION FILE cnbx-20200831_cal.xml EX-101.CAL 36697
13 XBRL DEFINITION FILE cnbx-20200831_def.xml EX-101.DEF 65655
14 XBRL LABEL FILE cnbx-20200831_lab.xml EX-101.LAB 171840
15 XBRL PRESENTATION FILE cnbx-20200831_pre.xml EX-101.PRE 137485
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 201285699
SIC: 2834 Pharmaceutical Preparations